John E. Kerrigan

2.7k citations
54 papers · 2.2k · 1 hit paper · h-index 25

Impact in

  • Toxicology top 2%
    • Cancer therapeutics and mechanisms
    • DNA and Nucleic Acid Chemistry
    • RNA and protein synthesis mechanisms
    • Genomics, phytochemicals, and oxidative stress
    • Advanced biosensing and bioanalysis techniques

Papers in

    • RNA Interference and Gene Delivery 6
    • Cancer therapeutics and mechanisms 5
    • Protein Kinase Regulation and GTPase Signaling 4
    • Biochemical and Molecular Research 4
    • DNA and Nucleic Acid Chemistry 4
    • Glycosylation and Glycoproteins Research 3
    • Synthesis and Biological Evaluation 5

John E. Kerrigan

54 papers receiving 2.1k citations

John E. Kerrigan's Hit Papers

Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane 2007 · 501 citations
5010+6+12Years since publication100200300400500

Peers

John E. Kerrigan
Comparison fields: 5 of 111
  • Toxicology 89
  • Molecular Biology 1.2k
  • Cardiology and Cardiovascular Medicine 358
  • Cancer Research 236
  • Physiology 78
Replace Elisabetta Leo with:
Elisabetta Leo United Kingdom
Frank J. Schoenen United States
Dayong Zhai United States
Gerald M. Wilson United States
Yong‐Su Zhen China
Patrick J. Duriez United Kingdom
Annette R. Khaled United States
Robert J. Hickey United States
Richard L. Momparler Canada
Craig Beeson United States
John E. Kerrigan relative to Elisabetta Leo United Kingdom Elisabetta Leo's profile →
Citations per field
00.5×5.4×
Elisabetta Leo · 1×
Citations per year

Countries citing papers authored by John E. Kerrigan

Since Specialization
Citations

This map shows the geographic impact of John E. Kerrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Kerrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Kerrigan more than expected).

Fields of papers citing papers by John E. Kerrigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Kerrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Kerrigan. The network helps show where John E. Kerrigan may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Kerrigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Kerrigan Line = papers co-authored together John E. Kerrigan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane
Hit paper breakdown →
2007501
2 2013172
3 2003109
4 201673
5 200670
6 201568
7 200166
8 199863
9 201362
10 200461
11 200358
12 201257
13 199255
14 199449
15 201649
16 201146
17 200942
18 200539
19 199537
20 201537

About John E. Kerrigan

John E. Kerrigan is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cancer Research and Pharmacology, having authored 54 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Evaluation (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Synthesis and Biological Activity (4 papers), Biochemical and Molecular Research (4 papers), DNA and Nucleic Acid Chemistry (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Toxicology (89 citations), Molecular Biology (1.2k citations), Cardiology and Cardiovascular Medicine (358 citations), Cancer Research (236 citations) and Physiology (78 citations). John E. Kerrigan has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Daniel S. Pilch, Leroy F. Liu, Yi Lisa Lyu, Yuan‐Chin Tsai, Chao‐Po Lin, Yi Ban, Anna M. Azarova, Malvika Kaul, Joseph R. Bertino and Christopher M. Barbieri. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Biological Chemistry, Oncotarget and Archives of Biochemistry and Biophysics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact